338 related articles for article (PubMed ID: 30777088)
1. Higher doses of naloxone are needed in the synthetic opiod era.
Moss RB; Carlo DJ
Subst Abuse Treat Prev Policy; 2019 Feb; 14(1):6. PubMed ID: 30777088
[TBL] [Abstract][Full Text] [Related]
2. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
[No Abstract] [Full Text] [Related]
3. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
4. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
5. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
[TBL] [Abstract][Full Text] [Related]
6. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
[TBL] [Abstract][Full Text] [Related]
7. Naloxone interventions in opioid overdoses: a systematic review protocol.
Shaw LV; Moe J; Purssell R; Buxton JA; Godwin J; Doyle-Waters MM; Brasher PMA; Hau JP; Curran J; Hohl CM
Syst Rev; 2019 Jun; 8(1):138. PubMed ID: 31186071
[TBL] [Abstract][Full Text] [Related]
8. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
[TBL] [Abstract][Full Text] [Related]
9. On the front lines of the opioid epidemic: Rescue by naloxone.
Skolnick P
Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
[TBL] [Abstract][Full Text] [Related]
11. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
12. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
[TBL] [Abstract][Full Text] [Related]
13. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
[No Abstract] [Full Text] [Related]
14. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose.
Krotulski AJ; Chapman BP; Marks SJ; Ontiveros ST; Devin-Holcombe K; Fogarty MF; Trieu H; Logan BK; Merchant RC; Babu KM
Clin Toxicol (Phila); 2022 Feb; 60(2):197-204. PubMed ID: 34278904
[TBL] [Abstract][Full Text] [Related]
15. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
[No Abstract] [Full Text] [Related]
16. Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.
Rock P; Slavova S; Westgate PM; Nakamura A; Walsh SL
Drug Alcohol Depend; 2024 Feb; 255():111062. PubMed ID: 38157702
[TBL] [Abstract][Full Text] [Related]
17. Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.
Moss RB; Pryor MM; Baillie R; Kudrycki K; Friedrich C; Reed M; Carlo DJ
PLoS One; 2020; 15(6):e0234683. PubMed ID: 32544184
[TBL] [Abstract][Full Text] [Related]
18. Abuse of fentanyl: An emerging problem to face.
Kuczyńska K; Grzonkowski P; Kacprzak Ł; Zawilska JB
Forensic Sci Int; 2018 Aug; 289():207-214. PubMed ID: 29902699
[TBL] [Abstract][Full Text] [Related]
19. Treatment of opioid overdose: current approaches and recent advances.
Britch SC; Walsh SL
Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
[TBL] [Abstract][Full Text] [Related]
20. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
